Global and Europe Dermatology Medication Market - Analysis and Outlook to 2022

August 2017 | 116 pages | ID: GC8857C01FFEN
EU Research

Abstracts

This report presents a comprehensive overview of the Dermatology Medication market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Dermatology Medication industry.

This report focuses Global and Europe market, including details as following:

Key Players

• Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld
• BASF SE DE 67056 Ludwigshafen
• Bidachem S.p.A. IT 24040 Fornovo San Giovanni
• Cerbios-Pharma SA CH 6917 Barbengo
• CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing
• EUTICALS S.P.A. IT 26900 Lodi
• F Hoffmann-La Roche Ltd. CH 4070 Basel
• FORMOSA LABORATORIES, INC. TW 33842 Taoyuan
• GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai
• Helsinn Advanced Synthesis S.A. CH 6710 Biasca
• Instytut Farmaceutyczny PL 01-793 Warsaw
• LEO PHARMA A/S DK 2750 Ballerup
• OLON S.P.A. IT 20090 Rodano
• QILU TIANHE PHARMACEUTICAL CO., LTD. CN 250 105 Jinan
• SHANGHAI NEW HUALIAN PHARMACEUTICAL CO., LTD. CN 201419 Shanghai
• SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH DE 32423 Minden
• SUN PHARMACEUTICAL INDUSTRIES LIMITED IN 400 063 Mumbai
• TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva
• Transo-Pharm Handels GmbH DE 22962 Siek

Key Regions

• North America
• United States
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Key Product Type

Dermatology Medication Market, by Dermatology Medication

Tretinoin

Isotretinoin

Xanthotoxin

Cesium Chloride

Trichloroacetic Acid

Adapalene

Zinc Oxide

Asiatic Acid

Calcipotriol

Anthralin

Sulfur

Psoralen

Crotamiton

Acitretin

Tazarotene

Calamine

Carbamide

Ichthammol

Salicylic acid

Key Applications

• Department of Dermatology
• Pharmacy
• Hospital
• Clinic
  
  

Contents

1 MARKET OUTLINE

1.1 Research Methodology
  1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
  1.1.2 Data Source
Secondary Sources
Primary Sources
  1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
  1.5.1 Dermatology Medication Industry Chain Structure
    1.5.1.1 R&D
    1.5.1.2 Raw Materials (Components)
    1.5.1.3 Manufacturing Plants
    1.5.1.4 Regional Trading (Import Export and Local Sales)
    1.5.1.5 Online Sales Channel
    1.5.1.6 Offline Channel
    1.5.1.7 End Users
  1.5.2 Dermatology Medication Manufacturing
    1.5.2.1 Key Components
    1.5.2.2 Assembly Manufacturing
  1.5.3 Consumer Preference
  1.5.4 Behavioral Habits
  1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
  1.8.1 Development Trend
  1.8.2 Research Conclusion

2 GLOBAL DERMATOLOGY MEDICATION PRODUCT OVERVIEW

2.1 Global Dermatology Medication Market Sales Volume Revenue and Price 2012-2017
2.2 Dermatology Medication, by Dermatology Medication 2012-2017
  2.2.1 Global Dermatology Medication Sales Market Share by Dermatology Medication 2012-2017
  2.2.2 Global Dermatology Medication Revenue Market Share by Dermatology Medication 2012-2017
  2.2.3 Global Dermatology Medication Price by Dermatology Medication 2012-2017
  2.2.4 Tretinoin
  2.2.5 Isotretinoin
  2.2.6 Xanthotoxin
  2.2.7 Cesium Chloride
  2.2.8 Trichloroacetic Acid
Adapalene
Zinc Oxide
Asiatic Acid
Calcipotriol
Anthralin
Sulfur
Psoralen
Crotamiton
Acitretin
Tazarotene
Calamine
Carbamide
Ichthammol
Salicylic acid

3 EUROPE DERMATOLOGY MEDICATION PRODUCT OVERVIEW

3.1 Europe Dermatology Medication Market Sales Volume Revenue and Price 2012-2017
3.2 Dermatology Medication, by Dermatology Medication 2012-2017
  3.2.1 Europe Dermatology Medication Sales Market Share by Dermatology Medication 2012-2017
  3.2.2 Europe Dermatology Medication Revenue Market Share by Dermatology Medication 2012-2017
  3.2.3 Europe Dermatology Medication Price by Dermatology Medication 2012-2017
  3.2.4 Tretinoin
  3.2.5 Isotretinoin
  3.2.6 Xanthotoxin
  3.2.7 Cesium Chloride
  3.2.8 Trichloroacetic Acid
Adapalene
Zinc Oxide
Asiatic Acid
Calcipotriol
Anthralin
Sulfur
Psoralen
Crotamiton
Acitretin
Tazarotene
Calamine
Carbamide
Ichthammol
Salicylic acid

4 DERMATOLOGY MEDICATION TOP COMPANIES PROFILE

4.1 Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld
  4.1.1 Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Company Details and Competitors
  4.1.2 Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Key Dermatology Medication Models and Performance
  4.1.3 Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Business SWOT Analysis and Forecast
  4.1.4 Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.2 BASF SE DE 67056 Ludwigshafen
  4.2.1 BASF SE DE 67056 Ludwigshafen Company Details and Competitors
  4.2.2 BASF SE DE 67056 Ludwigshafen Key Dermatology Medication Models and Performance
  4.2.3 BASF SE DE 67056 Ludwigshafen Dermatology Medication Business SWOT Analysis and Forecast
  4.2.4 BASF SE DE 67056 Ludwigshafen Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.3 Bidachem S.p.A. IT 24040 Fornovo San Giovanni
  4.3.1 Bidachem S.p.A. IT 24040 Fornovo San Giovanni Company Details and Competitors
  4.3.2 Bidachem S.p.A. IT 24040 Fornovo San Giovanni Key Dermatology Medication Models and Performance
  4.3.3 Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Business SWOT Analysis and Forecast
  4.3.4 Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.4 Cerbios-Pharma SA CH 6917 Barbengo
  4.4.1 Cerbios-Pharma SA CH 6917 Barbengo Company Details and Competitors
  4.4.2 Cerbios-Pharma SA CH 6917 Barbengo Key Dermatology Medication Models and Performance
  4.4.3 Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Business SWOT Analysis and Forecast
  4.4.4 Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.5 CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing
  4.5.1 CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Company Details and Competitors
  4.5.2 CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Key Dermatology Medication Models and Performance
  4.5.3 CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Business SWOT Analysis and Forecast
  4.5.4 CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.6 EUTICALS S.P.A. IT 26900 Lodi
  4.6.1 EUTICALS S.P.A. IT 26900 Lodi Company Details and Competitors
  4.6.2 EUTICALS S.P.A. IT 26900 Lodi Key Dermatology Medication Models and Performance
  4.6.3 EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Business SWOT Analysis and Forecast
  4.6.4 EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.7 F Hoffmann-La Roche Ltd. CH 4070 Basel
  4.7.1 F Hoffmann-La Roche Ltd. CH 4070 Basel Company Details and Competitors
  4.7.2 F Hoffmann-La Roche Ltd. CH 4070 Basel Key Dermatology Medication Models and Performance
  4.7.3 F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Business SWOT Analysis and Forecast
  4.7.4 F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.8 FORMOSA LABORATORIES, INC. TW 33842 Taoyuan
  4.8.1 FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Company Details and Competitors
  4.8.2 FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Key Dermatology Medication Models and Performance
  4.8.3 FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Business SWOT Analysis and Forecast
  4.8.4 FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.9 GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai
  4.9.1 GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Company Details and Competitors
  4.9.2 GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Key Dermatology Medication Models and Performance
  4.9.3 GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Business SWOT Analysis and Forecast
  4.9.4 GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.10 Helsinn Advanced Synthesis S.A. CH 6710 Biasca
  4.10.1 Helsinn Advanced Synthesis S.A. CH 6710 Biasca Company Details and Competitors
  4.10.2 Helsinn Advanced Synthesis S.A. CH 6710 Biasca Key Dermatology Medication Models and Performance
  4.10.3 Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Business SWOT Analysis and Forecast
  4.10.4 Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Sales Volume Revenue Price Cost and Gross Margin
4.11 Instytut Farmaceutyczny PL 01-793 Warsaw
4.12 LEO PHARMA A/S DK 2750 Ballerup
4.13 OLON S.P.A. IT 20090 Rodano
4.14 QILU TIANHE PHARMACEUTICAL CO., LTD. CN 250 105 Jinan
4.15 SHANGHAI NEW HUALIAN PHARMACEUTICAL CO., LTD. CN 201419 Shanghai
4.16 SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH DE 32423 Minden
4.17 SUN PHARMACEUTICAL INDUSTRIES LIMITED IN 400 063 Mumbai
4.18 TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva
4.19 Transo-Pharm Handels GmbH DE 22962 Siek

5 DERMATOLOGY MEDICATION BY REGIONS 2012-2017

5.1 Global Dermatology Medication Sales Market Share by Regions 2012-2017
5.2 Global Dermatology Medication Revenue Market Share by Regions 2012-2017
5.3 Global Dermatology Medication Price by Regions 2012-2017
5.4 North America
  5.4.1 United States
  5.4.2 Canada
5.5 Latin America
  5.5.1 Mexico
  5.5.2 Brazil
  5.5.3 Argentina
  5.5.4 Others in Latin America
5.6 Europe
  5.6.1 Germany
  5.6.2 United Kingdom
  5.6.3 France
  5.6.4 Italy
  5.6.5 Spain
  5.6.6 Russia
  5.6.7 Netherland
  5.6.8 Others in Europe
5.7 Asia & Pacific
  5.7.1 China
  5.7.2 Japan
  5.7.3 India
  5.7.4 Korea
  5.7.5 Australia
  5.7.6 Southeast Asia
    5.7.6.1 Indonesia
    5.7.6.2 Thailand
    5.7.6.3 Philippines
    5.7.6.4 Vietnam
    5.7.6.5 Singapore
    5.7.6.6 Malaysia
    5.7.6.7 Others in Southeast Asia
5.8 Africa & Middle East
  5.8.1 South Africa
  5.8.2 Egypt
  5.8.3 Turkey
  5.8.4 Saudi Arabia
  5.8.5 Iran
  5.8.6 Others in Africa & Middle East

6 GLOBALDERMATOLOGY MEDICATION BY PLAYERS 2012-2017

6.1 Global Dermatology Medication Sales Volume Market Share by Brands 2012-2017
6.2 Global Dermatology Medication Revenue Share by Brands 2012-2017
6.3 Global Top Players Dermatology Medication Key Product Model and Market Performance
6.4 Global Top Players Dermatology Medication Key Target Consumers and Market Performance

7 EUROPEDERMATOLOGY MEDICATION BY PLAYERS 2012-2017

7.1 Europe Dermatology Medication Sales Volume Market Share by Brands 2012-2017
7.2 Europe Dermatology Medication Revenue Share by Brands 2012-2017
7.3 Europe Top Players Dermatology Medication Key Product Model and Market Performance
7.4 Europe Top Players Dermatology Medication Key Target Consumers and Market Performance

8 GLOBAL DERMATOLOGY MEDICATION BY CONSUMER 2012-2017

8.1 Global Dermatology Medication Sales Market Share by Consumer 2012-2017
8.2 Department of Dermatology
8.3 Pharmacy
8.4 Hospital
8.5 Clinic
8.6 Consuming Habit and Preference

9 EUROPE DERMATOLOGY MEDICATION BY CONSUMER 2012-2017

9.1 Europe Dermatology Medication Sales Market Share by Consumer 2012-2017
9.2 Department of Dermatology
9.3 Pharmacy
9.4 Hospital
9.5 Clinic
9.6 Consuming Habit and Preference

10 GLOBAL DERMATOLOGY MEDICATION MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Dermatology Medication Sales (), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Dermatology Medication Sales () Forecast by Regions (2017-2022)
10.3 Global Dermatology Medication Sales () Forecast by Application (2017-2022)
10.4 Global Dermatology Medication Sales () Forecast by Dermatology Medication (2017-2022)
10.5 Global Dermatology Medication Sales () Forecast by (2017-2022)

11 EUROPE DERMATOLOGY MEDICATION MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 Europe Dermatology Medication Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Europe Dermatology Medication Sales () Forecast by Regions (2017-2022)
11.3 Europe Dermatology Medication Sales () Forecast by Application (2017-2022)
11.4 Europe Dermatology Medication Sales () Forecast by Dermatology Medication (2017-2022)
11.5 Europe Dermatology Medication Sales () Forecast by (2017-2022)

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Dermatology Medication Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure Global Dermatology Medication Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Dermatology Medication Sales Volume () and Growth Rate (2012-2017)
Table Global Dermatology Medication Sales () by Dermatology Medication (2012-2017)
Table Global Dermatology Medication Sales Market Share by Dermatology Medication (2012-2017)
Figure Global Dermatology Medication Sales Market Share by Dermatology Medication in 2016
Table Global Dermatology Medication Revenue (Million USD) by Dermatology Medication (2012-2017)
Table Global Dermatology Medication Revenue Market Share by Dermatology Medication (2012-2017)
Figure Global Dermatology Medication Revenue Market Share by Dermatology Medication in 2016
Table Global Dermatology Medication Price () by Dermatology Medication (2012-2017)
Table Top Players of Tretinoin Dermatology Medication Products List
Figure Global Tretinoin Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Isotretinoin Dermatology Medication Products List
Figure Global Isotretinoin Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Xanthotoxin Dermatology Medication Products List
Figure Global Xanthotoxin Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Cesium Chloride Dermatology Medication Products List
Figure Global Cesium Chloride Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Trichloroacetic Acid Dermatology Medication Products List
Figure Global Trichloroacetic Acid Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Global Dermatology Medication Sales () by (2012-2017)
Table Global Dermatology Medication Sales Market Share by (2012-2017)
Figure Global Dermatology Medication Sales Market Share by in 2016
Table Global Dermatology Medication Revenue (Million USD) by (2012-2017)
Table Global Dermatology Medication Revenue Market Share by (2012-2017)
Figure Global Dermatology Medication Revenue Market Share by in 2016
Table Global Dermatology Medication Price () by (2012-2017)
Table Global Dermatology Medication Sales () by (2012-2017)
Table Global Dermatology Medication Sales Market Share by (2012-2017)
Figure Global Dermatology Medication Sales Market Share by in 2016
Table Global Dermatology Medication Revenue (Million USD) by (2012-2017)
Table Global Dermatology Medication Revenue Market Share by (2012-2017)
Figure Global Dermatology Medication Revenue Market Share by in 2016
Table Global Dermatology Medication Price () by (2012-2017)
Table Europe Dermatology Medication Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure Europe Dermatology Medication Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Dermatology Medication Sales Volume () and Growth Rate (2012-2017)
Table Europe Dermatology Medication Sales () by Dermatology Medication (2012-2017)
Table Europe Dermatology Medication Sales Market Share by Dermatology Medication (2012-2017)
Figure Europe Dermatology Medication Sales Market Share by Dermatology Medication in 2016
Table Europe Dermatology Medication Revenue (Million USD) by Dermatology Medication (2012-2017)
Table Europe Dermatology Medication Revenue Market Share by Dermatology Medication (2012-2017)
Figure Europe Dermatology Medication Revenue Market Share by Dermatology Medication in 2016
Table Europe Dermatology Medication Price () by Dermatology Medication (2012-2017)
Table Top Players of Tretinoin Dermatology Medication Products List
Figure Europe Tretinoin Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Isotretinoin Dermatology Medication Products List
Figure Europe Isotretinoin Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Xanthotoxin Dermatology Medication Products List
Figure Europe Xanthotoxin Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Cesium Chloride Dermatology Medication Products List
Figure Europe Cesium Chloride Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Top Players of Trichloroacetic Acid Dermatology Medication Products List
Figure Europe Trichloroacetic Acid Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Europe Dermatology Medication Sales () by (2012-2017)
Table Europe Dermatology Medication Sales Market Share by (2012-2017)
Figure Europe Dermatology Medication Sales Market Share by in 2016
Table Europe Dermatology Medication Revenue (Million USD) by (2012-2017)
Table Europe Dermatology Medication Revenue Market Share by (2012-2017)
Figure Europe Dermatology Medication Revenue Market Share by in 2016
Table Europe Dermatology Medication Price () by (2012-2017)
Table Europe Dermatology Medication Sales () by (2012-2017)
Table Europe Dermatology Medication Sales Market Share by (2012-2017)
Figure Europe Dermatology Medication Sales Market Share by in 2016
Table Europe Dermatology Medication Revenue (Million USD) by (2012-2017)
Table Europe Dermatology Medication Revenue Market Share by (2012-2017)
Figure Europe Dermatology Medication Revenue Market Share by in 2016
Table Europe Dermatology Medication Price () by (2012-2017)
Table Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Company Details and Competitors
Table Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Key Dermatology Medication Models and Performance
Table Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Business SWOT Analysis and Forecast
Table Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Osterreichische Ichthyol-Gesellschaft m.b.H. nunmehr KG AT 6100 Seefeld Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table BASF SE DE 67056 Ludwigshafen Company Details and Competitors
Table BASF SE DE 67056 Ludwigshafen Key Dermatology Medication Models and Performance
Table BASF SE DE 67056 Ludwigshafen Dermatology Medication Business SWOT Analysis and Forecast
Table BASF SE DE 67056 Ludwigshafen Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure BASF SE DE 67056 Ludwigshafen Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure BASF SE DE 67056 Ludwigshafen Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure BASF SE DE 67056 Ludwigshafen Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure BASF SE DE 67056 Ludwigshafen Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table Bidachem S.p.A. IT 24040 Fornovo San Giovanni Company Details and Competitors
Table Bidachem S.p.A. IT 24040 Fornovo San Giovanni Key Dermatology Medication Models and Performance
Table Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Business SWOT Analysis and Forecast
Table Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Bidachem S.p.A. IT 24040 Fornovo San Giovanni Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table Cerbios-Pharma SA CH 6917 Barbengo Company Details and Competitors
Table Cerbios-Pharma SA CH 6917 Barbengo Key Dermatology Medication Models and Performance
Table Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Business SWOT Analysis and Forecast
Table Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Cerbios-Pharma SA CH 6917 Barbengo Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Company Details and Competitors
Table CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Key Dermatology Medication Models and Performance
Table CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Business SWOT Analysis and Forecast
Table CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. CN 401 121 Chongqing Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table EUTICALS S.P.A. IT 26900 Lodi Company Details and Competitors
Table EUTICALS S.P.A. IT 26900 Lodi Key Dermatology Medication Models and Performance
Table EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Business SWOT Analysis and Forecast
Table EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure EUTICALS S.P.A. IT 26900 Lodi Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table F Hoffmann-La Roche Ltd. CH 4070 Basel Company Details and Competitors
Table F Hoffmann-La Roche Ltd. CH 4070 Basel Key Dermatology Medication Models and Performance
Table F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Business SWOT Analysis and Forecast
Table F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure F Hoffmann-La Roche Ltd. CH 4070 Basel Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Company Details and Competitors
Table FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Key Dermatology Medication Models and Performance
Table FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Business SWOT Analysis and Forecast
Table FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Company Details and Competitors
Table GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Key Dermatology Medication Models and Performance
Table GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Business SWOT Analysis and Forecast
Table GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure GLENMARK PHARMACEUTICALS LIMITED IN 400 099 Mumbai Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table Helsinn Advanced Synthesis S.A. CH 6710 Biasca Company Details and Competitors
Table Helsinn Advanced Synthesis S.A. CH 6710 Biasca Key Dermatology Medication Models and Performance
Table Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Business SWOT Analysis and Forecast
Table Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Sales(Million Unit) and Growth Rate (%)(2012-2017)
Figure Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Sales Market Share (%) in Global (2012-2017)
Figure Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Helsinn Advanced Synthesis S.A. CH 6710 Biasca Dermatology Medication Revenue Market Share (%) in Global (2012-2017)
Table Instytut Farmaceutyczny PL 01-793 Warsaw Company Details and Competitors
Table LEO PHARMA A/S DK 2750 Ballerup Company Details and Competitors
Table OLON S.P.A. IT 20090 Rodano Company Details and Competitors
Table QILU TIANHE PHARMACEUTICAL CO., LTD. CN 250 105 Jinan Company Details and Competitors
Table SHANGHAI NEW HUALIAN PHARMACEUTICAL CO., LTD. CN 201419 Shanghai Company Details and Competitors
Table SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH DE 32423 Minden Company Details and Competitors
Table SUN PHARMACEUTICAL INDUSTRIES LIMITED IN 400 063 Mumbai Company Details and Competitors
Table TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Company Details and Competitors
Table Transo-Pharm Handels GmbH DE 22962 Siek Company Details and Competitors
Table Global Dermatology Medication Sales () by Regions (2012-2017)
Table Global Dermatology Medication Sales Share by Regions (2012-2017)
Figure Global Dermatology Medication Sales Market Share by Regions in 2016
Figure Global Dermatology Medication Sales Market Share by Regions in 2017
Table Global Dermatology Medication Revenue (Million USD) by Regions (2012-2017)
Table Global Dermatology Medication Revenue Market Share by Regions (2012-2017)
Figure Global Dermatology Medication Revenue Market Share by Regions in 2016
Figure Global Dermatology Medication Revenue Market Share by Regions in 2017
Table Global Dermatology Medication Price () by Regions (2012-2017)
Table North America Dermatology Medication Sales () by Regions (2012-2017)
Table North America Dermatology Medication Revenue (Million USD) by Regions (2012-2017)
Figure North America Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Latin America Dermatology Medication Sales () by Regions (2012-2017)
Table Latin America Dermatology Medication Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Europe Dermatology Medication Sales () by Regions (2012-2017)
Table Europe Dermatology Medication Revenue (Million USD) by Regions (2012-2017)
Figure Europe Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Dermatology Medication Sales () by Regions (2012-2017)
Table Asia & Pacific Dermatology Medication Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Dermatology Medication Sales () by Regions (2012-2017)
Table Africa & Middle East Dermatology Medication Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Global Dermatology Medication Sales Volume () by Key Players 2012-2017
Table Global Dermatology Medication Sales Volume Market Share by Key Players 2012-2017
Figure Global Dermatology Medication Sales Volume Market Share by Key Players 2016
Figure Global Dermatology Medication Sales Volume Market Share by Key Players 2017
Table Global Dermatology Medication Revenue (Million USD) by Key Players 2012-2017
Table Global Dermatology Medication Revenue Market Share by Key Players 2012-2017
Figure Global Dermatology Medication Revenue Market Share by Key Players 2016
Figure Global Dermatology Medication Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Europe Dermatology Medication Sales Volume () by Key Players 2012-2017
Table Europe Dermatology Medication Sales Volume Market Share by Key Players 2012-2017
Figure Europe Dermatology Medication Sales Volume Market Share by Key Players 2016
Figure Europe Dermatology Medication Sales Volume Market Share by Key Players 2017
Table Europe Dermatology Medication Revenue (Million USD) by Key Players 2012-2017
Table Europe Dermatology Medication Revenue Market Share by Key Players 2012-2017
Figure Europe Dermatology Medication Revenue Market Share by Key Players 2016
Figure Europe Dermatology Medication Revenue Market Share by Key Players 2017
Table Europe Top Players Key Product Model and Market Performance
Table Europe Top Players Key Target Consumers and Market Performance
Table Global Dermatology Medication Sales () by Consumer (2012-2017)
Figure Global Dermatology Medication Sales Market Share by Consumer (2012-2017)
Figure Global Dermatology Medication Sales Market Share by Consumer in 2016
Figure Global Department of Dermatology Dermatology Medication Sales () and Growth Rate (2012-2017)
Figure Global Pharmacy Dermatology Medication Sales () and Growth Rate (2012-2017)
Figure Global Hospital Dermatology Medication Sales () and Growth Rate (2012-2017)
Figure Global Clinic Dermatology Medication Sales () and Growth Rate (2012-2017)
Table Europe Dermatology Medication Sales () by Consumer (2012-2017)
Figure Europe Dermatology Medication Sales Market Share by Consumer (2012-2017)
Figure Europe Dermatology Medication Sales Market Share by Consumer in 2016
Figure Europe Department of Dermatology Dermatology Medication Sales () and Growth Rate (2012-2017)
Figure Europe Pharmacy Dermatology Medication Sales () and Growth Rate (2012-2017)
Figure Europe Hospital Dermatology Medication Sales () and Growth Rate (2012-2017)
Figure Europe Clinic Dermatology Medication Sales () and Growth Rate (2012-2017)
Figure Global Dermatology Medication Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Dermatology Medication Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Dermatology Medication Price () Trend Forecast (2017-2022)
Table Global Dermatology Medication Sales () Forecast by Regions (2017-2022)
Table Global Dermatology Medication Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Dermatology Medication Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Dermatology Medication Sales Volume Share Forecast by Regions in 2022
Table Global Dermatology Medication Sales () Forecast by Application (2017-2022)
Figure Global Dermatology Medication Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Dermatology Medication Sales Volume Market Share Forecast by Application in 2022
Table Global Dermatology Medication Sales () Forecast by Dermatology Medication (2017-2022)
Figure Global Dermatology Medication Sales () Forecast by Dermatology Medication (2017-2022)
Figure Global Dermatology Medication Sales Volume Market Share Forecast by Dermatology Medication in 2022
Table Global Dermatology Medication Sales () Forecast by (2017-2022)
Figure Global Dermatology Medication Sales () Forecast by (2017-2022)
Figure Global Dermatology Medication Sales Volume Market Share Forecast by in 2022
Figure Europe Dermatology Medication Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Europe Dermatology Medication Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Europe Dermatology Medication Price () Trend Forecast (2017-2022)
Table Europe Dermatology Medication Sales () Forecast by Regions (2017-2022)
Table Europe Dermatology Medication Sales Volume Share Forecast by Regions (2017-2022)
Figure Europe Dermatology Medication Sales Volume Share Forecast by Regions (2017-2022)
Figure Europe Dermatology Medication Sales Volume Share Forecast by Regions in 2022
Table Europe Dermatology Medication Sales () Forecast by Application (2017-2022)
Figure Europe Dermatology Medication Sales Volume Market Share Forecast by Application (2017-2022)
Figure Europe Dermatology Medication Sales Volume Market Share Forecast by Application in 2022
Table Europe Dermatology Medication Sales () Forecast by Dermatology Medication (2017-2022)
Figure Europe Dermatology Medication Sales () Forecast by Dermatology Medication (2017-2022)
Figure Europe Dermatology Medication Sales Volume Market Share Forecast by Dermatology Medication in 2022
Table Europe Dermatology Medication Sales () Forecast by (2017-2022)
Figure Europe Dermatology Medication Sales () Forecast by (2017-2022)
Figure Europe Dermatology Medication Sales Volume Market Share Forecast by in 2022